Hidetaka Hara

Cell and tissue xenotransplantation: clinical purpose determines translational strategy and therapeutic endpoints

Solid organ xenotransplantation is moving into early clinical use, whereas living xenogeneic cells and tissues are being developed for distinct therapeutic tasks. Product-based discussions can obscure differences in required functional duration, immune exposure, consequences of p...